B cell zone reticular cell microenvironments shape CXCL13 gradient formation.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
22 07 2020
Historique:
received: 21 04 2018
accepted: 12 03 2020
entrez: 24 7 2020
pubmed: 24 7 2020
medline: 10 9 2020
Statut: epublish

Résumé

Through the formation of concentration gradients, morphogens drive graded responses to extracellular signals, thereby fine-tuning cell behaviors in complex tissues. Here we show that the chemokine CXCL13 forms both soluble and immobilized gradients. Specifically, CXCL13

Identifiants

pubmed: 32699279
doi: 10.1038/s41467-020-17135-2
pii: 10.1038/s41467-020-17135-2
pmc: PMC7376062
doi:

Substances chimiques

CXCL13 protein, human 0
Chemokine CXCL13 0
Cxcl13 protein, mouse 0
Recombinant Proteins 0
CTSB protein, human EC 3.4.22.1
Cathepsin B EC 3.4.22.1
Ctsb protein, mouse EC 3.4.22.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3677

Subventions

Organisme : Medical Research Council
ID : MR/K021125/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/N006453/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/F004729/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/R001235/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K01580X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15073
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204829
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0601156
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT0905024MA
Pays : United Kingdom

Références

Br J Rheumatol. 1997 Jul;36(7):735-43
pubmed: 9255106
Immunity. 2007 Jul;27(1):160-71
pubmed: 17658276
Nature. 1986 Nov 27-Dec 3;324(6095):369-72
pubmed: 2431318
CPT Pharmacometrics Syst Pharmacol. 2015 Nov;4(11):615-29
pubmed: 26783498
J Immunol. 1999 Jan 15;162(2):1064-70
pubmed: 9916734
Blood. 2013 May 16;121(20):4101-9
pubmed: 23558016
Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3849-53
pubmed: 7731994
J Immunol. 2003 Jun 1;170(11):5470-4
pubmed: 12759423
Cell. 2007 Jan 26;128(2):245-56
pubmed: 17254964
J Biol Chem. 2001 Jan 12;276(2):944-51
pubmed: 11016923
Methods Mol Biol. 2017;1591:43-57
pubmed: 28349474
Int Immunol. 2010 Jun;22(6):413-9
pubmed: 20508253
Integr Biol (Camb). 2009 Oct;1(10):602-12
pubmed: 20023777
Nature. 1998 Jun 4;393(6684):440-2
pubmed: 9623998
Nat Rev Immunol. 2009 Jan;9(1):15-27
pubmed: 19079135
Trends Ecol Evol. 1999 Nov;14(11):427-432
pubmed: 10511718
Pharmacol Ther. 2008 Nov;120(2):197-217
pubmed: 18793669
Nat Rev Immunol. 2013 Nov;13(11):815-29
pubmed: 24319779
Annu Rev Biochem. 2005;74:385-410
pubmed: 15952892
Int J Biochem Cell Biol. 2008;40(6-7):1185-98
pubmed: 18243768
Exp Hematol. 2006 Aug;34(8):1021-32
pubmed: 16863908
Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2319-2324
pubmed: 28193885
Science. 2010 Apr 23;328(5977):498-501
pubmed: 20413500
Acta Histochem. 2007;109(1):15-28
pubmed: 17224179
Nat Immunol. 2007 Nov;8(11):1255-65
pubmed: 17893676
PLoS Biol. 2016 Jul 14;14(7):e1002515
pubmed: 27415420
Nat Rev Cancer. 2006 Oct;6(10):764-75
pubmed: 16990854
Nat Immunol. 2014 Jul;15(7):623-30
pubmed: 24813163
Nat Immunol. 2007 Sep;8(9):992-1000
pubmed: 17660822
Nat Immunol. 2004 Sep;5(9):943-52
pubmed: 15300245
Biometrika. 1950 Jun;37(1-2):17-23
pubmed: 15420245
FEBS Lett. 2003 Jan 30;535(1-3):55-60
pubmed: 12560078
Nature. 2014 Dec 11;516(7530):254-8
pubmed: 25274307
J Cell Sci. 2012 Oct 1;125(Pt 19):4463-74
pubmed: 22797918
Brain Connect. 2011;1(5):367-75
pubmed: 22432451
Open Biol. 2017 Oct;7(10):
pubmed: 29070611
Nature. 1998 Feb 19;391(6669):799-803
pubmed: 9486651
Nature. 2000 Jul 20;406(6793):309-14
pubmed: 10917533
PLoS Comput Biol. 2013;9(2):e1002916
pubmed: 23468606
J Exp Med. 1998 Feb 16;187(4):655-60
pubmed: 9463416
Philos Trans R Soc Lond B Biol Sci. 2012 Dec 24;368(1611):20120029
pubmed: 23267182
Nat Rev Immunol. 2008 Oct;8(10):764-75
pubmed: 18825130
Faraday Discuss. 2015;184:401-24
pubmed: 26419209
Immunity. 2016 Jan 19;44(1):59-72
pubmed: 26789922
Methods. 2015 Oct 15;88:81-8
pubmed: 25637032
PLoS Negl Trop Dis. 2014 Sep 25;8(9):e3194
pubmed: 25255101
Nucleic Acids Res. 2019 Jan 10;47(1):210-220
pubmed: 30445553
Nature. 2006 Sep 21;443(7109):355-8
pubmed: 16971952
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1885-90
pubmed: 12571364
J Exp Med. 2011 Nov 21;208(12):2497-510
pubmed: 22042977
Methods Enzymol. 1997;287:233-50
pubmed: 9330326
Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15376-81
pubmed: 18832162
Immunity. 2010 May 28;32(5):703-13
pubmed: 20471289
Immunity. 2017 Jul 18;47(1):80-92.e4
pubmed: 28709801
Immunity. 2017 Apr 18;46(4):609-620
pubmed: 28389069
Methods Enzymol. 2016;570:87-118
pubmed: 26921943
Biophys J. 2006 Jul 1;91(1):113-21
pubmed: 16603487
J Exp Med. 2000 Jan 3;191(1):61-76
pubmed: 10620605
Biochem Biophys Res Commun. 2016 Sep 2;477(4):602-606
pubmed: 27338641
Cell. 1996 Dec 13;87(6):1037-47
pubmed: 8978608
Pharmaceuticals (Basel). 2017 Aug 09;10(3):
pubmed: 28792472
Front Immunol. 2018 May 22;9:1073
pubmed: 29872430

Auteurs

Jason Cosgrove (J)

York Computational Immunology Lab, University of York, York, UK.
Centre for Immunology and Infection, Department of Biology and Hull York Medical School, University of York, York, UK.
Department of Electronic Engineering, University of York, York, UK.

Mario Novkovic (M)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Stefan Albrecht (S)

Theodor Kocher Institute, University of Bern, Bern, Switzerland.

Natalia B Pikor (NB)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Zhaoukun Zhou (Z)

Department of Biology, University of York, York, UK.
Biological Physical Sciences Institute (BPSI), University of York, York, UK.
Department of Physics, University of York, York, UK.

Lucas Onder (L)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Urs Mörbe (U)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Jovana Cupovic (J)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Helen Miller (H)

Department of Biology, University of York, York, UK.
Biological Physical Sciences Institute (BPSI), University of York, York, UK.
Department of Physics, University of York, York, UK.

Kieran Alden (K)

York Computational Immunology Lab, University of York, York, UK.
Department of Electronic Engineering, University of York, York, UK.

Anne Thuery (A)

Centre for Immunology and Infection, Department of Biology and Hull York Medical School, University of York, York, UK.

Peter O'Toole (P)

Department of Biology, University of York, York, UK.

Rita Pinter (R)

Kennedy Institute of Rheumatology at the University of Oxford, Oxford, UK.

Simon Jarrett (S)

Kennedy Institute of Rheumatology at the University of Oxford, Oxford, UK.

Emily Taylor (E)

Centre for Immunology and Infection, Department of Biology and Hull York Medical School, University of York, York, UK.

Daniel Venetz (D)

Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.

Manfred Heller (M)

Department of Clinical Research, University of Bern, Bern, Switzerland.

Mariagrazia Uguccioni (M)

Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.

Daniel F Legler (DF)

Biotechnology Institute Thurgau (BITg) at the University of Konstanz, Kreuzlingen, Switzerland.

Charles J Lacey (CJ)

York Computational Immunology Lab, University of York, York, UK.

Andrew Coatesworth (A)

York Teaching Hospital NHS Foundation Trust, York, UK.

Wojciech G Polak (WG)

Department of Surgery, Erasmus University Medical Centre, Rotterdam, Netherlands.

Tom Cupedo (T)

Department of Hematology, Erasmus University Medical Centre, Rotterdam, Netherlands.

Bénedicte Manoury (B)

Institut Necker Enfants Malades, INSERM U1151- CNRS UMR 8253, 149 rue de Sèvres 75015 Paris, France Université René Descartes, 75005, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Marcus Thelen (M)

Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.

Jens V Stein (JV)

Department of Oncology, Microbiology and Immunology, University of Fribourg, Fribourg, Switzerland.

Marlene Wolf (M)

Theodor Kocher Institute, University of Bern, Bern, Switzerland.

Mark C Leake (MC)

Department of Biology, University of York, York, UK. mark.leake@york.ac.uk.
Biological Physical Sciences Institute (BPSI), University of York, York, UK. mark.leake@york.ac.uk.
Department of Physics, University of York, York, UK. mark.leake@york.ac.uk.

Jon Timmis (J)

York Computational Immunology Lab, University of York, York, UK. jon.timmis@sunderland.ac.uk.
Department of Electronic Engineering, University of York, York, UK. jon.timmis@sunderland.ac.uk.

Burkhard Ludewig (B)

Institute of Immunobiology, Kantonsspital St. Gallen, St. Gallen, Switzerland. burkhard.ludewig@kssg.ch.

Mark C Coles (MC)

York Computational Immunology Lab, University of York, York, UK. mark.coles@kennedy.ox.ac.uk.
Kennedy Institute of Rheumatology at the University of Oxford, Oxford, UK. mark.coles@kennedy.ox.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH